Finally, even if PSMA-PET is the imaging modality with the best diagnostic accuracy for prostate cancer staging, it can lead to false-positive metastasis findings (positive predictive value in BCR, 0.84%25), especially in the bone. The gene discussed is FOLH1; the disease is prostate carcinoma.